Associate Medical Director, Gynecologic Oncology

About the role

Natera is seeking an Associate Medical Director to lead medical strategy and clinical development for its cell-free DNA and liquid biopsy portfolio in gynecologic oncology. The role involves directing clinical evidence-generation plans, overseeing medical education for healthcare providers, and collaborating across research, commercial, and regulatory teams. The successful candidate will drive the clinical adoption of molecular testing solutions for minimal residual disease and recurrence monitoring.

Responsibilities

• Partner with the Sr. Medical Director on the clinical development of cfDNA molecular diagnostics and liquid biopsy assays.
• Direct the execution of clinical strategies and evidence-generation plans to demonstrate clinical utility.
• Oversee medical education and scientific communications for gynecologic oncology stakeholders.
• Represent the company at medical congresses and maintain relationships with external experts and cooperative groups.
• Collaborate with R&D, biostatistics, and clinical operations on protocol development and peer-reviewed publications.

Required skills

• Gynecologic Oncology
• Clinical Development
• Molecular Diagnostics
• Liquid Biopsy
• Clinical Trial Design
• Oncology

Nice to have

• Clinical Diagnostics
• Biopharma Industry Experience

Qualifications

• M.D. or D.O. with board certification in Gynecologic Oncology
• Medical Oncology with a significant gynecologic oncology focus
• Minimum 5 years of post-training experience in oncology
• At least 3 years of clinical trial experience

Benefits

• Annual performance incentive bonus
• Long-term equity awards
• Health insurance
• Dental insurance
• Vision insurance
• 401(k) with company match
• Paid time off
• Company holidays
• Fertility care benefits
• Pregnancy and baby bonding leave

About the Company

Natera is a global leader in cell-free DNA testing, dedicated to oncology, women’s health, and organ health. The company aims to make personalized genetic testing and diagnostics part of the standard of care to enable earlier and more targeted interventions.